Application of flow cytometry to platelet disorders.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Seminars in Thrombosis and Hemostasis

• Publication date

  2004-10-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1055/S-2004-835671PMID 15497093
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention.

  2003cited by this paper
• Soluble CD40L: Risk Prediction After Acute Coronary Syndromes

  2003cited by this paper
• The effects of sevoflurane and desflurane in vitro on platelet–leukocyte adhesion in whole blood

  2003cited by this paper
• Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans.

  2003cited by this paper
• A new flow cytometric method for measurement of von Willebrand factor activity

  2003cited by this paper
• Endothelial and platelet activation in acute ischemic stroke and its etiological subtypes.

  2003cited by this paper
• Clopidogrel but not aspirin reduces P‐selectin expression and formation of platelet‐leukocyte aggregates in patients with atherosclerotic vascular disease *

  2003cited by this paper
• Antiplatelet therapy in peripheral arterial disease. Consensus statement.

  2003cited by this paper
• Effects of short-term racing activity on platelet and neutrophil activation in dogs.

  2003cited by this paper
• Effect of propofol on adhesion of activated platelets to leukocytes in human whole blood

  2003cited by this paper
• Soluble CD40 ligand in acute coronary syndromes.

  2003cited by this paper
• Effect of a single dose aspirin on platelets in humans with multiple risk factors for coronary artery disease.

  2003cited by this paper
• Dietary flavanols and procyanidin oligomers from cocoa (Theobroma cacao) inhibit platelet function.

  2003cited by this paper
• Platelet GPIIb/IIIa Is Activated and Platelet-Leukocyte Coaggregates Formed in vivo during Hemodialysis

  2002cited by this paper
• Circulating platelet-derived microparticles with procoagulant activity may be a potential cause of thrombosis in uremic patients.

  2002cited by this paper
• Aspirin and Postoperative Bleeding After Coronary Artery Bypass Grafting

  2002cited by this paper
• Platelet and Leukocyte Activation Correlate with the Severity of Septic Organ Dysfunction

  2002cited by this paper
• Attempt to improve the diagnosis of immune thrombocytopenia by combined use of two different platelet autoantibodies assays (PAIgG and MACE).

  2002cited by this paper
• In vivo effect of haemodilution with saline on coagulation: a randomized controlled trial.

  2002cited by this paper
• Frequency of aspirin resistance in patients with congestive heart failure treated with antecedent aspirin.

  2002cited by this paper
• Clopidogrel, but not abciximab, reduces platelet leukocyte conjugates and P‐selectin expression in a human ex vivo in vitro model

  2002cited by this paper
• Effects of insulin on platelet and leukocyte activity in whole blood.

  2002cited by this paper
• Markers of platelet activation and platelet-leukocyte interaction in patients with myeloproliferative syndromes.

  2002cited by this paper
• Platelet glycoprotein IIb/IIIa receptor antagonist (abciximab) inhibited platelet activation and promoted skin flap survival after ischemia/reperfusion injury.

  2002cited by this paper
• Platelet P-Selectin Levels in Relation to Plasma Soluble P-Selectin and &bgr;-Thromboglobulin Levels in Atrial Fibrillation

  2002cited by this paper
• Inhibition of ADP-induced P-selectin Expression and Platelet-Leukocyte Conjugate Formation by Clopidogrel and the P2Y12 Receptor Antagonist AR-C69931MX but not Aspirin

  2002cited by this paper
• Circulating monocyte-platelet aggregates are an early marker of acute myocardial infarction.

  2001cited by this paper
• Leukocyte-platelet aggregation, platelet surface P-selectin, and platelet surface glycoprotein IIIa after percutaneous coronary intervention: Effects of dalteparin or unfractionated heparin in combination with abciximab.

  2001cited by this paper
• Flow Cytometry Detection of Platelet Procoagulant Activity and Microparticles in Patients with Unstable Angina Treated by Percutaneous Coronary Angioplasty and Stent Implantation

  2001cited by this paper
• In vivo platelet activation in atherothrombotic stroke is not determined by polymorphisms of human platelet glycoprotein IIIa or Ib

  2001cited by this paper
• Neonatal Platelet Activation in Preeclampsia

  2001cited by this paper
• Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement.

  2001cited by this paper
• Identification of the platelet ADP receptor targeted by antithrombotic drugs

  2001cited by this paper
• Circulating Monocyte-Platelet Aggregates Are a More Sensitive Marker of In Vivo Platelet Activation Than Platelet Surface P-Selectin: Studies in Baboons, Human Coronary Intervention, and Human Acute Myocardial Infarction

  2001cited by this paper
• Heparin management during cardiopulmonary bypass.

  2001cited by this paper
• Microparticles from Patients with Multiple Organ Dysfunction Syndrome and Sepsis Support Coagulation through Multiple Mechanisms

  2001cited by this paper
• GPIIb-IIIa Antagonist-induced Reduction in Platelet Surface Factor V/Va Binding and Phosphatidylserine Expression in Whole Blood

  2000cited by this paper
• Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes.

  2000cited by this paper
• Congenital disorders of platelet signal transduction.

  2000cited by this paper
• Changes in surface expression of platelet membrane glycoproteins and progression of heart transplant vasculopathy.

  2000cited by this paper
• Evaluation of platelet function by flow cytometry.

  2000cited by this paper
• P-Selectin expression, platelet aggregates, and platelet-derived microparticle formation are increased in peripheral arterial disease

  2000cited by this paper
• Flow Cytometric Monitoring of Glycoprotein IIb/IIIa Blockade and Platelet Function in Patients With Acute Myocardial Infarction Receiving Reteplase, Abciximab, and Ticlopidine: Continuous Platelet Inhibition by the Combination of Abciximab and Ticlopidine

  2000cited by this paper
• High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14.

  2000cited by this paper
• The Effects of Aprotinin on Platelets In Vitro Using Whole Blood Flow Cytometry

  2000cited by this paper
• Role of soluble and platelet-bound P-selectin in discriminating cardiac from noncardiac chest pain at presentation in the emergency department.

  2000cited by this paper
• Effects of extracorporeal circulation and heparin on the phenotype of platelet surface antigens following heart surgery.

  2000cited by this paper
• Platelet and Platelet-derived Microparticle Surface Factor V/Va Binding in Whole Blood: Differences between Neonates and Adults

  2000cited by this paper
• The effects of heparin, protamine, and heparinase 1 on platelets in vitro using whole blood flow cytometry.

  2000cited by this paper
• Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans

  2000cited by this paper
• CD40L Activation in Circulating Platelets in Patients with Acute Coronary Syndrome

  2000cited by this paper
• The flow cytometer model markedly affects measurement of ex vivo whole blood platelet-bound P-selectin expression in patients with chest pain: are we comparing apples with oranges.

  1999cited by this paper
• Free and Total Platelet Glycoprotein IIb/IIIa Measurement in Whole Blood by Quantitative Flow Cytometry during and after Infusion of c7E3 Fab in Patients Undergoing PTCA

  1999cited by this paper
• Chronic venous insufficiency is associated with increased platelet and monocyte activation and aggregation.

  1999cited by this paper
• Quantifying GPIIb/IIIa receptor binding using 2 monoclonal antibodies: discriminating abciximab and small molecular weight antagonists.

  1999cited by this paper
• Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction.

  1999cited by this paper
• Inhibition of Fibrinogen Binding and Surface Recruitment of GpIIb/IIIa as Dose-Dependent Effects of the RGD-Mimetic MK-852

  1998cited by this paper
• Patients with venous stasis ulceration have increased monocyte-platelet aggregation.

  1998cited by this paper
• Correlation of thrombosis with increased platelet turnover in thrombocytosis.

  1998cited by this paper
• Platelet and neutrophil activation during cardiac surgical procedures: impact of cardiopulmonary bypass.

  1998cited by this paper
• Effect of Glycoprotein IIb-IIIa Receptor Antagonism on Platelet Membrane Glycoproteins after Coronary Stent Placement

  1998cited by this paper
• Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease.

  1998cited by this paper
• Expression of ligand-induced binding sites on glycoprotein IIb/IIIa complexes and the effect of various inhibitors.

  1998cited by this paper
• Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide.

  1998cited by this paper
• Platelet activation in Alzheimer disease.

  1998cited by this paper
• Heparin-induced Thrombocytopenia: Towards Consensus

  1998cited by this paper
• Whole blood analysis of reticulated platelets: improvements of detection and assay stability.

  1998cited by this paper
• Increased Fraction of Circulating Activated Platelets in Acute and Previous Cerebrovascular Ischemia

  1998cited by this paper
• Platelet Hyporeactivity in Very Low Birth Weight Neonates

  1997cited by this paper
• Platelet microparticles and calcium homeostasis in acute coronary ischemias

  1997cited by this paper
• Effect of Ca2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate.

  1997cited by this paper
• Antiplatelet effect of ticlopidine after coronary stenting.

  1997cited by this paper
• Induction of cytokine expression in leukocytes by binding of thrombin-stimulated platelets.

  1997cited by this paper
• A sensitive and specific functional flow cytometric assay for the diagnosis of heparin‐induced thrombocytopenia

  1997cited by this paper
• Increased neutrophil-platelet adhesion in patients with unstable angina.

  1996cited by this paper
• A Platelet Activation-specific Monoclonal Antibody that Recognizes a Receptor-induced Binding Site on Canine Fibrinogen

  1996cited by this paper
• Platelet function and platelet-leukocyte adhesion in symptomatic coronary heart disease. Effects of intravenous magnesium.

  1996cited by this paper
• Platelet activation in acute myocardial infarction and unstable angina is inhibited by nitric oxide donors.

  1996cited by this paper
• Flow cytometry: a clinical test of platelet function.

  1996cited by this paper
• In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function.

  1996cited by this paper
• Platelet activation and coronary stent implantation. Effect of antithrombotic therapy.

  1996cited by this paper
• A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee.

  1996cited by this paper
• Flow Cytometric Detection of Activated Platelets: Comparison of Determining Shape Change, Fibrinogen Binding, and P-Selectin Expression

  1995cited by this paper
• Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry

  1995cited by this paper
• Leukocyte activation with platelet adhesion after coronary angioplasty: a mechanism for recurrent disease?

  1995cited by this paper
• Platelet GPIIb/IIIa receptor occupancy studies using a novel fluoresceinated cyclic Arg-Gly-Asp peptide.

  1995cited by this paper
• A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents

  1995cited by this paper
• Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty.

  1995cited by this paper
• Flow cytometric detection of circulating activated platelets and platelet hyper-responsiveness in pre-eclampsia and pregnancy.

  1994cited by this paper
• Fluorescein derivatization of fibrinogen for flow cytometric analysis of fibrinogen binding to platelets.

  1994cited by this paper
• Platelet-leukocyte activation and modulation of adhesion receptors in pediatric patients with congenital heart disease undergoing cardiopulmonary bypass.

  1994cited by this paper
• Reticulated platelet counts in patients undergoing autologous bone marrow transplantation: An aid in assessing marrow recovery

  1994cited by this paper
• The activation-induced decrease in the platelet surface expression of the glycoprotein Ib-IX complex is reversible.

  1994cited by this paper
• Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia.

  1994cited by this paper
• Quantitation of soluble fibrinogen binding to platelets by fluorescence-activated flow cytometry.

  1994cited by this paper
• Reversible Inhibition of Human Platelet Activation by Hypothermia In Vivo and In Vitro

  1994cited by this paper
• Large platelets continue to circulate in an activated state after myocardial infarction

  1994cited by this paper
• Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration.

  1994cited by this paper
• The pathophysiological role of platelets during myocardial ischaemia.

  1994cited by this paper
• Flow-cytometric analysis of mepacrine-labelled platelets in patients with end-stage renal failure.

  1993cited by this paper

• Flow Cytometry Assessment of Platelet Phenotype, Function, and Cellular Interactions: Guidelines for Optimization and Assay Performance.

  2025cites this paper
• Mepacrine Flow Cytometry Assay for the Diagnosis of Platelet δ-granule Defects: Literature Review on Methods—Towards a Shared Detailed Protocol

  2024influential citation
• Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies

  2024cites this paper
• Preanalytical conditions for multiparameter platelet flow cytometry

  2023cites this paper
• Validation of PAMFix, A Novel Platelet Stabilization Product, for Use on Flow Cytometric Analysis of Pigtailed Macaque (Macaca nemestrina) Blood.

  2023cites this paper
• Non-severe burn injury causes sustained platelet hyperreactivity.

  2023cites this paper
• Flow cytometry immunophenotyping of healthy platelets and hospitalized patients with suspected platelet dysfunction: Challenges for establishing a cutoff value

  2023cites this paper
• Assay validity of point-of-care platelet function tests in thrombocytopenic blood samples

  2022cites this paper
• Platelets after burn injury – hemostasis and beyond

  2022cites this paper
• Flow cytometry for evaluating platelet immunophenotyping and function in patients with thrombocytopenia

  2022cites this paper
• Elevated CD9 expression as a potential biomarker for diagnosis of Bernard-Soulier syndrome

  2022cites this paper
• Recurrent melena in a diagnosed case of Bernard Soulier syndrome

  2021cites this paper
• Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet Physiology

  2021cites this paper
• Thrombocytopathies: Not Just Aggregation Defects—The Clinical Relevance of Procoagulant Platelets

  2021cites this paper
• Vielfältige Methoden – unterschiedlicher Nutzen

  2021cites this paper
• Platelets

  2021cites this paper
• Platelet Phenotyping and Function Testing in Thrombocytopenia

  2021cites this paper
• Platelets in Diagnostic

  2021cites this paper
• Morphometric and Nanomechanical Features of Platelets from Women with Early Pregnancy Loss Provide New Evidence of the Impact of Inherited Thrombophilia

  2021cites this paper
• Guidelines for panel design, optimization, and performance of whole blood multi-color flow cytometry of platelet surface markers

  2020cites this paper
• Bernard-Soulier syndrome

  2020cites this paper
• Current methods of measuring platelet activity: pros and cons

  2020cites this paper
• Platelet Flow Cytometry: Instrument Setup, Controls, and Panel Performance

  2020cites this paper
• Glycophorin A-based exclusion of red blood cells for flow cytometric analysis of platelet glycoprotein expression in citrated whole blood

  2020cites this paper
• Flow cytometric evaluation of platelet–leukocyte conjugate stability over time: methodological implications of sample handling and processing

  2020cites this paper
• Evaluation of the procoagulant properties of a newly developed platelet modified lysate product

  2020cites this paper
• Clinical Tests of Platelet Function

  2019cites this paper
• Glanzmann\'s Thrombasthenia: A Review of Literature

  2019cites this paper
• Platelet Function During Extracorporeal Membrane Oxygenation in Adult Patients

  2019cites this paper
• A Novel Rapid Method of Red Blood Cell and Platelet Permeabilization and Staining for Flow Cytometry Analysis

  2019cites this paper
• Thrombus-Targeted Theranostic Microbubbles for Simultaneous Ultrasound Diagnosis and Therapy of Thrombosis

  2018cites this paper
• Diagnosis of platelet function disorders: A standardized, rational, and modular flow cytometric approach

  2018cites this paper
• Using flow cytometry to monitor glycoprotein IIb-IIIa activation

  2018cites this paper
• When do we need platelet function analysis ?

  2017cites this paper
• Impacts of exercise on platelet and vascular function in humans

  2017cites this paper
• Imaging flow cytometry in the assessment of leukocyte-platelet aggregates.

  2017cites this paper
• Exploration biologique des thrombopathies constitutionnelles - déficit en CalDAG-GEFI : un exemple de recherche translationnelle

  2017cites this paper
• Bernard-Soulier Syndrome

  2016cites this paper
• Platelet Function Determined by Flow Cytometry: New Perspectives?

  2016cites this paper
• Thrombocytopenia model with minimal manipulation of blood cells allowing whole blood assessment of platelet function

  2016cites this paper
• Durchflusszytometrische Immunphänotypisierung in der klinischen Diagnostik

  2016cites this paper
• [Flow-cytometric immunophenotyping in clinical diagnostics].

  2016cites this paper
• The effect of centrifugation speed and time on pre-analytical platelet activation

  2016cites this paper
• Diagnosis of Glanzmann thrombasthenia by whole blood impedance analyzer (MEA) vs. light transmission aggregometry

  2015cites this paper
• The evaluation of platelet function in HIV infected, asymptomatic treatment-naïve individuals using flow cytometry.

  2015cites this paper
• Platelet activation in a population of critically ill dogs as measured with whole blood flow cytometry and thromboelastography.

  2015cites this paper
• Measurement of monocyte‐platelet aggregates by imaging flow cytometry

  2015cites this paper
• Flow cytometric detection of MPL (CD110) as a diagnostic tool for differentiation of congenital thrombocytopenias

  2015cites this paper
• formation in a model of type 1 diabetes-dihydroxyflavonol reduce platelet function and delay thrombus

  2014cites this paper
• Analysis of platelet function and dysfunction

  2014cites this paper
• Platelets: Still a Therapeutical Target for Haemostatic Disorders

  2014cites this paper
• The flavonols quercetin and 3′,4′-dihydroxyflavonol reduce platelet function and delay thrombus formation in a model of type 1 diabetes

  2014cites this paper
• An overview of platelet indices and methods for evaluating platelet function in thrombocytopenic patients

  2014influential citation
• Platelets in Hemostasis: Inherited and Acquired Qualitative Disorders

  2014cites this paper
• First Report of Elevated Monocyte-Platelet Aggregates in Healthy Children

  2013cites this paper
• State of the art in platelet function testing.

  2013cites this paper
• New horizons in platelets flow cytometry.

  2013cites this paper
• Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3′,4′-dihydroxyflavonol and quercetin

  2013cites this paper
• Effect of aerobic interval training and caffeine on blood platelet function.

  2013cites this paper
• Treatment with quercetin and 3′,4′-dihydroxyflavonol inhibits platelet function and reduces thrombus formation in vivo

  2013cites this paper
• Platelet flow cytometry.

  2013cites this paper
• Testing platelet function.

  2013cites this paper
• Utilising the zebrafish model organism to study the effect of FLCN in early embryonic development and Genotyping and platelet phenotyping of cases of rare inherited platelet based bleeding disorders

  2013cites this paper
• Red Cells, Leucocytes and Platelets

  2013cites this paper
• Using Platelet Function Testing to Guide Antiplatelet Therapy

  2013cites this paper
• In-vitro-Effekt von Hydroxyethylstärke 130/0,42 auf die canine Thrombozytenfunktion

  2013cites this paper
• State of the Art in Platelet Function Testing

  2013cites this paper
• Effects of outdoor air pollutants on platelet activation in people with type 2 diabetes

  2012cites this paper
• Overcoming aspirin treatment failure in diabetes

  2012cites this paper
• The effect of the flavonols quercetin and 3', 4' dihydroxyflavonol on platelet function in vitro and in vivo

  2012cites this paper
• Critical Reviews in Clinical Laboratory Sciences

  2012cites this paper
• Assessment of platelet function.

  2012cites this paper
• Multicolor flow cytometry for evaluation of platelet surface antigens and activation markers.

  2012cites this paper
• Advances in the monitoring of anti-P2Y12 therapy

  2012cites this paper
• Low-dose sirolimus-eluting hydroxyapatite coating on stents does not increase platelet activation and adhesion ex vivo

  2012cites this paper
• Platelet function testing and the effect of natural products on platelet activation

  2012cites this paper
• Blood Platelets and von Willebrand Disease

  2011cites this paper
• The Human Endogenous Circadian System Causes Greatest Platelet Activation during the Biological Morning Independent of Behaviors

  2011cites this paper
• The effects of eccentrically biased versus conventional resistance training in older adults

  2011cites this paper
• Platelets: pleiotropic roles in atherogenesis and atherothrombosis.

  2010cites this paper
• Role of Immunophenotyping in the Diagnosis of Inherited Platelet Disorders

  2010cites this paper
• Glanzmann thrombasthenia: an update.

  2010cites this paper
• Stellenwert der Thrombozytenfunktionsdiagnostik

  2010cites this paper
• Fortschritte in der Thrombozytenfunktionsdiagnostik

  2010cites this paper
• Diagnosis and Management of Inherited Platelet Disorders

  2010cites this paper
• [Progress in diagnostic evaluation of platelet function disorders].

  2010cites this paper
• Beitrag der Durchflusszytometrie zur Diagnose und Differentialdiagnose der Thrombozytopenie / Contribution of flow cytometry to the diagnosis and differential diagnosis of thrombocytopenia

  2010cites this paper
• Contribution of flow cytometry to the diagnosis and differential diagnosis of thrombocytopenia 1

  2010cites this paper
• Patterns of activation and deposition of platelets exposed to the polymeric surface of the paclitaxel eluting stent

  2009cites this paper
• The role of platelet thrombin receptors PAR1 and PAR4 in platelet activation

  2009cites this paper
• Longitudinal platelet reactivity to acute psychological stress among older men and women

  2009cites this paper
• A rapid flow cytometric technique for the detection of platelet‐monocyte complexes, activated platelets and platelet‐derived microparticles

  2009cites this paper
• Comparison of platelet aggregation using light transmission and multiple electrode aggregometry in Glanzmann thrombasthenia

  2009cites this paper
• Die Auswirkung von Apnoe auf hämostaseologische Kenngrößen bei gesunden männlichen Probanden

  2009cites this paper
• Coagulation property of hyaluronic acid–collagen/chitosan complex film

  2008cites this paper
• Diagnostic tool for Glanzmann's thrombasthenia clinicopathologic spectrum.

  2008cites this paper
• Effects of depressive and anxious symptoms on norepinephrine and platelet P-selectin responses to acute psychological stress among elderly caregivers.

  2008cites this paper
• Flow cytometric measurement of CD62P (P‐selectin) expression on platelets: a multicenter optimization and standardization effort

  2008cites this paper
• Neutrophil CD40 enhances platelet-mediated inflammation.

  2008cites this paper
• Platelet activation in the postoperative period after lung transplantation.

  2008cites this paper